Independent

Published November 12, 2026

Trump administration will fund new research on controversial psychedelic drug ibogaine

Read the full story at Independent

They include the first potential medicines made from psilocybin, the active ingredient in magic mushrooms, and MDMA, also called ecstasy. Decisions on.